Australian clinicians’ experiences with assessing and treating depression in people with multiple sclerosis

Takeaway

  • Clinicians in Australia recognize that depression is common in people with multiple sclerosis (MS) and has a significant impact on well-being and outcomes, but they do not commonly screen for depression and lack information and tools to effectively manage depression.

Why this matters

  • Depression is common in people with MS and carries a significant burden, but it is commonly underdiagnosed and undertreated.

  • Results from this study support the need to develop simple and easily applied screening guidelines and practical resources for MS-treating clinicians, and emphasize the need for multidisciplinary collaboration to improve depression management in people with MS.